Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 53 of 2905 for:    Pancreatic Cancer

Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03392571
Recruitment Status : Withdrawn (Study was stopped due to lack of funding)
First Posted : January 8, 2018
Last Update Posted : May 7, 2019
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Pancreatic Cancer Research Team

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 30, 2020
Estimated Study Completion Date : December 30, 2020